As of 2026-09-17, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is (2.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 16.06 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -113.3%.
The range of the Relative Valuation is (2.07) - (2.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 28.3x | 23.9x |
| Forward P/E multiples | 20.9x - 26.3x | 22.1x |
| Fair Price | (2.07) - (2.45) | (2.14) |
| Upside | -112.9% - -115.3% | -113.3% |
| Date | P/E |
| 2026-09-16 | -172.44 |
| 2026-09-15 | -168.47 |
| 2026-09-14 | -168.68 |
| 2026-09-11 | -166.43 |
| 2026-09-10 | -166.86 |
| 2026-09-09 | -174.48 |
| 2026-09-08 | -174.59 |
| 2026-09-04 | -179.53 |
| 2026-09-03 | -176.52 |
| 2026-09-02 | -180.49 |
| 2026-09-01 | -178.45 |
| 2026-08-31 | -181.67 |
| 2026-08-28 | -181.35 |
| 2026-08-27 | -180.92 |
| 2026-08-26 | -181.25 |
| 2026-08-25 | -180.28 |
| 2026-08-24 | -179.20 |
| 2026-08-21 | -179.74 |
| 2026-08-20 | -178.13 |
| 2026-08-19 | -185.11 |
| 2026-08-18 | -188.44 |
| 2026-08-17 | -189.62 |
| 2026-08-14 | -196.92 |
| 2026-08-13 | -195.85 |
| 2026-08-12 | -186.61 |
| 2026-08-11 | -186.51 |
| 2026-08-10 | -183.29 |
| 2026-08-07 | -185.22 |
| 2026-08-06 | -183.61 |
| 2026-08-05 | -189.83 |
| 2026-08-04 | -192.20 |
| 2026-08-03 | -191.98 |
| 2026-07-31 | -178.78 |
| 2026-07-30 | -183.82 |
| 2026-07-29 | -177.06 |
| 2026-07-28 | -212.17 |
| 2026-07-27 | -209.70 |
| 2026-07-24 | -212.49 |
| 2026-07-23 | -199.28 |
| 2026-07-22 | -202.08 |
| 2026-07-21 | -204.12 |
| 2026-07-20 | -202.83 |
| 2026-07-17 | -206.69 |
| 2026-07-16 | -213.13 |
| 2026-07-15 | -201.65 |
| 2026-07-14 | -197.57 |
| 2026-07-13 | -199.50 |
| 2026-07-10 | -201.75 |
| 2026-07-09 | -197.46 |
| 2026-07-08 | -185.75 |